Skip to main content
Premium Trial:

Request an Annual Quote

Source MDx, Pfizer to ID Biomarkers for Cancer and Inflammatory Rx Response

NEW YORK (GenomeWeb News) — Molecular diagnostics company Source MDx today said it will work with Pfizer to uncover biomarkers linked to response and resistance to certain of the drug giant’s cancer and inflammatory candidate compounds.
 
As part of the multi-year alliance, the firms will use genomic and RNA transcription profiling to identify inflammation and cancer-related biomarkers in whole blood and circulating rare cells.
 
Validated biomarkers “will lead to joint commercial opportunities in companion diagnostics,” the companies said.
 
Source MDx stands to receive an undisclosed equity investment and technology license payment from Pfizer, plus undisclosed R&D funding over the term of the alliance.
 
Source MDx said it will also retain commercial rights to diagnostic biomarkers discovered and validated during the collaboration.
 
Financial terms of the alliance were not disclosed.

The Scan

Alzheimer's Risk Gene Among Women

CNN reports that researchers have found that variants in MGMT contribute to Alzheimer's disease risk among women but not men.

Still Hanging Around

The Guardian writes that persistent pockets of SARS-CoV-2 in the body could contribute to long COVID.

Through a Little Spit

Enteric viruses like norovirus may also be transmitted through saliva, not just the fecal-oral route, according to New Scientist.

Nature Papers Present Method to Detect Full Transcriptome, Viruses Infecting Asgard Archaea, More

In Nature this week: VASA-seq approach to detect full transcriptome, analysis of viruses infecting Asgard archaea, and more.